Anupam Rasayan launches open offer for Bliss GVS Pharma after acquiring 43.3% stake
Published on: June 9, 2026, 10:39 p.m. | Source: CNBC TV18
Anupam Rasayan launches SEBI regulated open offer to buy up to 26% more of Bliss GVS Pharma at ₹299 per share after acquiring 43.3%, funding via ₹300 crore debt and a global fund.
